You have read all your free articles, to continue reading subscribe to read the rest of this content.
AstraZeneca has announces the sale of its West Chester site in Ohio, US, to National Resilience, a technology-focused manufacturing company dedicated to broadening access to complex medicines. “As part of our long-term strategy to ensure our global supply network remains fit for the future, we Already a subscriber Login You…
Promore Pharma announces that a manufacturing agreement has been entered with APL for the production of investigational medicinal product for its LL-37 Phase IIb trial in patients with hard-to-heal leg ulcers. The trial will be conducted in Europe with a planned start for patient enrolment in 201Already a subscriber Login…
Aprea Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for APR-246 in combination with azacitidine for the treatment of myelodysplastic syndromes (MDS) with a susceptible TP53 mutation. MDS represents a spectrum of hematopoieAlready a subscriber Login You have read all your free…
Allergan has entered into a global agreement with AstraZeneca to develop and commercialize ATM-AVI, an investigational, fixed-dose antibiotic combining aztreonam and avibactam. Together, the two companies will evaluate the combination to treat serious infections caused by metallo βlactamase MBL-Already a subscriber Login You have read all your free articles, to…
